GlassScriptPhysician profile
Kimber Boyko
NPI 1386602043
$235.76
in general payments reported to CMS, 2019-2025
10 companies · $62.30 in 2025
The $62.30 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $66.82 · 2020: $14.70 · 2021: $19.44 · 2023: $18.02 · 2024: $54.48 · 2025: $62.30.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $135.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $134.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $40.80 | 2021-2025 | Vistaseal |
| Intuitive Surgical, INC. | $31.11 | 2023-2024 | Da Vinci Surgical System |
| Hologic Sales and Service, LLC | $29.88 | 2025 | Magseed, Magtrace |
| Kerecis Limited | $29.58 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Shire North American Group INC | $28.59 | 2019 | |
| Smith+Nephew, INC. | $25.16 | 2019 | |
| Davol INC. | $15.17 | 2024 | Arista Ah Flexitip |
| Takeda Pharmaceuticals U.S.A., INC. | $14.70 | 2020 | |
| Covidien LP | $13.07 | 2019 | |
| Merit Medical Systems INC | $7.70 | 2024 | Savi Scout |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimber Boyko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.